Zobrazeno 1 - 10
of 59
pro vyhledávání: '"S. C. Hadler"'
Autor:
R. T. Chen, J. W. Glasser, P. H. Rhodes, R. L. Davis, W. E. Barlow, R. S. Thompson, J. P. Mullooly, S. B. Black, H. R. Shinefield, C. M. Vadheim, S. M. Marcy, J. I. Ward, R. P. Wise, S. G. Wassilak, S. C. Hadler, null the Vaccine Safety Datalink Team
Publikováno v:
PEDIATRICS. 99:765-773
Objective. To fill the large “gaps and limitations” in current scientific knowledge of rare vaccine adverse events identified in recent reviews of the Institute of Medicine. Methods. Computerized information on immunization, medical outcomes, and
Autor:
S Brooks, S C Hadler, P Parsons, J C Grabau, Charles W. LeBaron, S Friedman, Guthrie S. Birkhead, L Barr-Gale, J Fuhrman, E Maes
Publikováno v:
American Journal of Public Health. 86:1551-1556
OBJECTIVES: This study assessed measles vaccination rates and risk factors for lack of vaccination among preschool children enrolled in the Special Supplemental Food Program for Women, Infants, and Children (WIC) during the 1991 measles epidemic in N
Autor:
S C Hadler, L E Markowitz, Peter M. Strebel, W L Atkinson, S F Davis, S Friedman, K S Scanlon, Roland W. Sutter
Publikováno v:
American Journal of Public Health. 83:1011-1015
OBJECTIVES. During an epidemic of measles among preschool children in New York City, an investigation was conducted in 12 city hospitals to estimate reporting efficiency of measles to the New York City Department of Health. METHODS. Measles cases wer
Publikováno v:
MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports. 47(RR-8)
These revised recommendations of the Advisory Committee on Immunization Practices (ACIP) on measles, mumps, and rubella prevention supersede recommendations published in 1989 and 1990. This statement summarizes the goals and current strategies for me
Publikováno v:
JAMA. 277(24)
To describe patterns among imported measles cases to the United States.Descriptive analysis of national case-based surveillance data on measles cases.United States in the period 1986 through 1994.All reported confirmed cases of measles.Demographic va
Autor:
R T, Chen, J W, Glasser, P H, Rhodes, R L, Davis, W E, Barlow, R S, Thompson, J P, Mullooly, S B, Black, H R, Shinefield, C M, Vadheim, S M, Marcy, J I, Ward, R P, Wise, S G, Wassilak, S C, Hadler
Publikováno v:
Pediatrics. 99(6)
To fill the large "gaps and limitations" in current scientific knowledge of rare vaccine adverse events identified in recent reviews of the Institute of Medicine.Computerized information on immunization, medical outcomes, and potential confounders on
Autor:
H S, Izurieta, R W, Sutter, P M, Strebel, B, Bardenheier, D R, Prevots, M, Wharton, S C, Hadler
Publikováno v:
MMWR. CDC surveillance summaries : Morbidity and mortality weekly report. CDC surveillance summaries. 46(2)
Despite the widespread availability of a safe and effective vaccine against tetanus, 201 cases of the disease were reported during 1991-1994. Of patients with known illness outcome, the case-fatality rate was 25%.1991-1994.Physician-diagnosed cases o
Publikováno v:
American family physician. 55(1)
This report concerning the immunization of adolescents (i.e., persons 11 to 21 years of age, as defined by the American Medical Association [AMA] and the American Academy of Pediatrics [AAP]) is a supplement to previous publications (i.e., MMWR 1994;
Publikováno v:
JAMA. 276(12)
To evaluate the economic consequences of introducing inactivated poliovirus vaccine (IPV) into the routine vaccination schedule in the United States to reduce vaccine-associated paralytic poliomyelitis (VAPP).Cost-benefit and cost-effectiveness model
Publikováno v:
Bulletin on the rheumatic diseases. 44(8)